Oct 14, 2026 04:03PM
Oct 1, 2026 08:00AM
Sep 28, 2026 08:00PM
Sep 9, 2026 07:25AM
Sep 4, 2026 06:31AM
Sep 3, 2026 06:56AM
Aug 24, 2026 04:00PM Belite Bio to Host Virtual Commercial Day on September 2, 2026
Aug 14, 2026 07:54AM
Aug 14, 2026 06:38AM
Aug 12, 2026 09:45PM
Aug 12, 2026 07:59AM
Aug 12, 2026 07:23AM
Aug 11, 2026 04:01PM
Aug 11, 2026 04:01PM Belite Bio Announces U.S. Food and Drug Administration Acceptance and Priority Review of New Drug Application for Tinlarebant for the Treatment of Stargardt Disease Type 1
Jul 20, 2026 08:00AM
Jul 20, 2026 08:00AM
Jun 16, 2026 06:44AM
Jun 15, 2026 03:02AM
Jun 12, 2026 09:30PM
May 22, 2026 09:33AM
May 21, 2026 06:38AM H.C. Wainwright Reiterates Buy Rating on Belite Bio, Inc, ADR (BLTE)
May 20, 2026 06:00AM
May 18, 2026 04:00PM
May 18, 2026 04:00PM
May 15, 2026 08:00AM
Apr 27, 2026 08:00AM
Apr 22, 2026 08:35AM
Apr 21, 2026 04:00PM Belite Bio begins FDA rolling submission for Stargardt disease treatment
Apr 21, 2026 04:00PM
Apr 13, 2026 06:38AM
Apr 7, 2026 07:46AM
Mar 4, 2026 08:42AM
Mar 4, 2026 06:42AM
Mar 3, 2026 09:37AM
Mar 2, 2026 06:00AM Belite Bio Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update
Jan 29, 2026 08:00AM
Jan 27, 2026 08:04AM
Jan 27, 2026 08:00AM
Jan 26, 2026 06:12AM
Dec 3, 2025 08:44AM
Dec 1, 2025 06:00AM
Dec 1, 2025 06:00AM New Hope for People Living with a Disease Once Deemed Untreatable: Belite Bio Announces Positive Topline Results from the Pivotal Global, Phase 3 DRAGON Trial of Tinlarebant in Adolescents with Starga
Nov 10, 2025 08:00AM
Sep 15, 2025 07:28AM
Sep 10, 2025 08:51AM
Aug 12, 2025 09:42AM
Aug 11, 2025 06:00AM
Jul 2, 2025 03:00AM
May 22, 2025 08:39AM Benchmark Reiterates Buy Rating on Belite Bio, Inc, ADR (BLTE)
May 21, 2025 03:00AM

334,273 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All